The Scope of Things
Episode: 26 - Digital Twins, Care-For-All European Platform, and the Impact and Future of Wearables and Microsampling
In this episode of the Scope of Things, host Deborah Borfitz brings you the monthly breakdown on current events, such as tailoring medications to individual patients using digital twins, the use of a skin biopsy test to diagnose neurodegenerative diseases, and the launch of a European-wide platform promoting access to care for all. She also speaks with Michael Snyder, chair of the department of genetics at Stanford University School of Medicine and director of the Center of Genomics and Personalized Medicine at Stanford, about the growing adoption of wearables and home microsampling—and how this will dramatically change clinical trials and care. Snyder also delves into the “Amazon-ing” of healthcare and how he envisions the creation and future of personalized metrics and customized interventions and how they can improve trial outcomes.
In this episode of the Scope of Things, host Deborah Borfitz brings you the monthly breakdown on current events, such as tailoring medications to individual patients using digital twins, the use of a skin biopsy test to diagnose neurodegenerative diseases, and the launch of a European-wide platform promoting access to care for all. She also speaks with Michael Snyder, chair of the department of genetics at Stanford University School of Medicine and director of the Center of Genomics and Personalized Medicine at Stanford, about the growing adoption of wearables and home microsampling—and how this will dramatically change clinical trials and care. Snyder also delves into the “Amazon-ing” of healthcare and how he envisions the creation and future of personalized metrics and customized interventions and how they can improve trial outcomes.